3D Bioprinter for the Development of Tissue Constructs and Microfluidic Devices

目前的RTI赠款申请是为购买3D生物打印机(RX1，AspectTM BiosSystems)以及在无菌条件下使用3D生物打印机所需的生物安全柜提供资金。RX1生物打印机配备了Aspects的Lab-on-a-Print技术，该技术可以通过单个微流控打印头实现多种生物材料和细胞的高分辨率。多材料沉积和图案化是通过Aspects的软件定制的，该软件允许在结构设计和制造中进行高水平的控制，从而实现3D异质和复杂结构制造。这款3D生物打印机将主要由以下列出的四个渥太华大学研究团队使用。然而，这些设备也将提供给研究界内的其他潜在用户。这四个研究小组是：

The present RTI grant application is to provide funds for the purchase of a 3D bioprinter (RX1, AspectTM Biosystems), along with a biological safety cabinet, required for the use of the 3D bioprinter under sterile conditions. The RX1 bioprinter is equipped with Aspect’s Lab-on-a-Printer technology, which enables high resolution of multiple biomaterials and cells through a single microfluidic printhead. Multi-material deposition and patterning is customized through Aspect’s software that allows a high level of control in structure design and fabrication, thereby enabling 3D heterogeneous and complex structure fabrication. The 3D bioprinter will be used primarily by the four uOttawa research teams listed below. However, the equipment will also be available to other potential users within the research community. The four research teams are: